VACCHI, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 6.588
NA - Nord America 6.482
AS - Asia 3.653
SA - Sud America 610
AF - Africa 135
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.551
Nazione #
US - Stati Uniti d'America 6.209
IT - Italia 4.042
SG - Singapore 1.135
CN - Cina 842
GB - Regno Unito 639
SE - Svezia 440
BR - Brasile 426
HK - Hong Kong 374
VN - Vietnam 359
DE - Germania 278
FR - Francia 207
RU - Federazione Russa 206
FI - Finlandia 181
CA - Canada 175
IN - India 156
NL - Olanda 146
TR - Turchia 137
JP - Giappone 136
KR - Corea 116
ID - Indonesia 94
UA - Ucraina 83
AU - Australia 73
MX - Messico 72
IE - Irlanda 64
AR - Argentina 62
BG - Bulgaria 59
PK - Pakistan 48
TN - Tunisia 47
PL - Polonia 43
BD - Bangladesh 39
EC - Ecuador 36
IQ - Iraq 34
ZA - Sudafrica 30
MY - Malesia 29
LT - Lituania 26
ES - Italia 25
CL - Cile 20
CO - Colombia 20
AT - Austria 19
PE - Perù 19
AE - Emirati Arabi Uniti 16
EG - Egitto 16
IR - Iran 16
SA - Arabia Saudita 16
JO - Giordania 15
BE - Belgio 13
HU - Ungheria 13
PT - Portogallo 13
VE - Venezuela 13
CH - Svizzera 11
PH - Filippine 11
TH - Thailandia 11
DK - Danimarca 10
KE - Kenya 10
RO - Romania 10
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
BZ - Belize 8
CZ - Repubblica Ceca 8
LU - Lussemburgo 8
MA - Marocco 8
NZ - Nuova Zelanda 8
OM - Oman 8
PY - Paraguay 8
TW - Taiwan 8
UZ - Uzbekistan 7
HR - Croazia 6
RS - Serbia 6
AZ - Azerbaigian 4
BO - Bolivia 4
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
MD - Moldavia 4
AL - Albania 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HN - Honduras 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
SI - Slovenia 2
SN - Senegal 2
BB - Barbados 1
BS - Bahamas 1
Totale 17.531
Città #
Singapore 769
Santa Clara 718
Ashburn 634
Fairfield 591
Chandler 419
Hong Kong 358
Milan 306
Rome 286
Southend 285
Woodbridge 262
San Jose 252
Nyköping 245
Houston 206
Hefei 183
Wilmington 174
Beijing 168
Seattle 168
London 167
Cambridge 162
Helsinki 155
Ann Arbor 141
New York 129
The Dalles 121
Los Angeles 119
Council Bluffs 117
Chicago 104
Bologna 97
Ho Chi Minh City 90
Hanoi 87
Seoul 87
Naples 76
San Diego 72
Florence 68
Jacksonville 68
Jakarta 67
Modena 65
Catania 59
Toronto 59
Shanghai 57
Sofia 57
Bari 56
Dearborn 55
Redwood City 52
Dublin 50
Tokyo 50
Bremen 49
Palermo 49
Princeton 49
Moscow 47
Perth 47
Dallas 46
Frankfurt am Main 44
Lauterbourg 42
São Paulo 42
Munich 41
North York 37
Salt Lake City 37
Turin 37
Orem 35
Verona 35
Cagliari 31
Genoa 31
Buffalo 30
Izmir 30
Eugene 27
Manchester 27
Atlanta 26
Chennai 26
Padova 25
Falls Church 24
Ankara 23
Guayaquil 23
Salerno 23
Warsaw 23
Parma 22
Da Nang 21
Mexico City 21
Columbus 19
Istanbul 19
Mumbai 19
Reggio Emilia 18
Rio de Janeiro 18
Bergamo 17
Boston 17
Brescia 17
Denver 17
Elk Grove Village 16
Haiphong 16
Johannesburg 16
Pisa 16
Santiago 16
Tampa 16
Venice 16
Brooklyn 15
Delhi 15
Treviso 15
Baghdad 14
Beauharnois 14
Ottawa 14
Phoenix 14
Totale 9.955
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.817
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.328
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 368
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 338
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 333
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 321
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 317
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 309
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 291
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 279
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 277
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 276
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 273
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 270
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 269
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 258
PREVALENZA, CORRELATI CLINICO-SEROLOGICI E CARATTERISTICHE RADIOLOGICHE DELL'INTERSTIZIOPATIA POLMONARE IN UN'AMPIA COORTE DI PAZIENTI AFFETTI DA SINDROME DI SJOGREN 256
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 252
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 250
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 246
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 241
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 238
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 236
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 231
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 223
Procedural pain management in the treatment of scleroderma digital ulcers 217
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 217
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 216
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 210
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 209
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 201
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 201
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 193
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 191
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 184
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 183
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 179
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 174
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 173
Vasculitis in a patient with mixed cryoglobulinemia treated with rituximab biosimilar CT-P10: a case report 170
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 162
Fibrosing interstitial lung disease in primary Sjogren syndrome 162
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 161
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 161
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 156
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 151
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 148
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 142
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 136
COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS 131
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 126
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 126
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 116
Reply to “ Sjögren's syndrome and pulmonary hypertension: Correspondence” 108
Reply to “Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjögren's Syndrome” 93
PROPOSAL OF CORE OUTCOME DOMAINS IN MIXED CRYOGLOBULINEMIC VASCULITIS 93
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 87
Sjögren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease 77
Personalized Medicine and Machine Learning: A Roadmap for the Future 56
Real-World Use of Anifrolumab for Articular Involvement in Systemic Lupus Erythematosus: A Monocentric Case Series and Systematic Review 55
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 33
Hemoglobin-to-Red Cell Distribution Width Ratio and Vitamin D Status as Early Predictors of Cardiovascular Risk in Primary Sjögren’s Syndrome 19
Totale 17.738
Categoria #
all - tutte 58.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 0 0 0 0 155 112 148
2021/20221.607 126 83 106 92 113 145 87 87 183 118 243 224
2022/20232.350 235 187 153 161 227 208 165 236 240 133 243 162
2023/20242.467 126 138 165 256 275 252 237 348 75 128 215 252
2024/20253.679 187 117 159 260 589 499 355 227 376 153 327 430
2025/20264.775 359 201 413 654 781 415 649 279 574 450 0 0
Totale 17.738